⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SER News
Serina Therapeutics, Inc.
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
globenewswire.com
SER
PFE
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
globenewswire.com
SER
PFE
Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
globenewswire.com
SER
Serina Therapeutics Provides Regulatory Update on SER-252 Program
globenewswire.com
SER
Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors
globenewswire.com
SER
Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease
globenewswire.com
SER